Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC: Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004, 7: 187-200. 10.1079/PHN2003588.
Hakkak R, Holley AW, Macleod SL, Simpson PM, Fuchs GJ, Jo CH, Kieber-Emmons T, Korourian S: Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res. 2005, 7: R627-R633. 10.1186/bcr1263.
Willett WC: Dietary fat plays a major role in obesity: no. Obes Rev. 2002, 3: 59-68. 10.1046/j.1467-789X.2002.00060.x.
Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO: The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr. 2000, 83 Suppl 1 (): S25-S32.
Fung TT, Hu FB, Holmes MD, Rosner BA, Hunter DJ, Colditz GA, Willett WC: Dietary patterns and the risk of postmenopausal breast cancer. Int J Cancer. 2005, 116: 116-121. 10.1002/ijc.20999.
Mattisson I, Wirfalt E, Wallstrom P, Gullberg B, Olsson H, Berglund G: High fat and alcohol intakes are risk factors of postmenopausal breast cancer: a prospective study from the Malmo diet and cancer cohort. Int J Cancer. 2004, 110: 589-597. 10.1002/ijc.20166.
Cho E, Spiegelman D, Hunter DJ, Chen WY, Stampfer MJ, Colditz GA, Willett WC: Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst. 2003, 95: 1079-1085.
Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, Fraser GE, Goldbohm RA, Graham S, Howe GR, et al: Cohort studies of fat intake and the risk of breast cancer: a pooled analysis. N Engl J Med. 1996, 334: 356-361. 10.1056/NEJM199602083340603.
Velie E, Kulldorff M, Schairer C, Block G, Albanes D, Schatzkin A: Dietary fat, fat subtypes, and breast cancer in postmenopausal women: a prospective cohort study. J Natl Cancer Inst. 2000, 92: 833-839. 10.1093/jnci/92.10.833.
Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, et al: Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006, 295: 629-642. 10.1001/jama.295.6.629.
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19: 403-410.
Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JF, Blamey RW, Nicholson RI: Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer. 1989, 59: 943-947.
Chiarle R, Pagano M, Inghirami G: The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res. 2001, 3: 91-94. 10.1186/bcr277.
Nelsen CJ, Kuriyama R, Hirsch B, Negron VC, Lingle WL, Goggin MM, Stanley MW, Albrecht JH: Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem. 2005, 280: 768-776.
Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL: Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA. 2002, 99: 1978-1983. 10.1073/pnas.032479999.
Nielsen NH, Loden M, Cajander J, Emdin SO, Landberg G: G1-S transition defects occur in most breast cancers and predict outcome. Breast Cancer Res Treat. 1999, 56: 105-112. 10.1023/A:1006208419350.
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.
Zhu Z, Jiang W, Thompson HJ: Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinog. 1999, 24: 241-245. 10.1002/(SICI)1098-2744(199904)24:4<241::AID-MC1>3.0.CO;2-P.
Wirfalt E, Mattisson I, Gullberg B, Johansson U, Olsson H, Berglund G: Postmenopausal breast cancer is associated with high intakes of omega6 fatty acids (Sweden). Cancer Causes Control. 2002, 13: 883-893. 10.1023/A:1021922917489.
Berglund G, Elmstahl S, Janzon L, Larsson SA: The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med. 1993, 233: 45-51.
Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G: The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001, 10: 489-499. 10.1097/00008469-200112000-00003.
Callmer E, Riboli E, Saracci R, Akesson B, Lindgarde F: Dietary assessment methods evaluated in the Malmo food study. J Intern Med. 1993, 233: 53-57.
Riboli E, Elmstahl S, Saracci R, Gullberg B, Lindgarde F: The Malmo Food Study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol. 1997, 26 Suppl 1 (): S161-S173. 10.1093/ije/26.suppl_1.S161.
Taylor HL, Jacobs DR, Schucker B, Knudsen J, Leon AS, Debacker G: A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978, 31: 741-755. 10.1016/0021-9681(78)90058-9.
Wallstrom P, Wirfalt E, Janzon L, Mattisson I, Elmstahl S, Johansson U, Berglund G: Fruit and vegetable consumption in relation to risk factors for cancer: a report from the Malmo Diet and Cancer Study. Public Health Nutr. 2000, 3: 263-271.
Willett WC, Howe GR, Kushi LH: Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997, 65: 1220S-1228S. discussion 1229S–1231S
Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ: Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutr. 2002, 5: 915-923. 10.1079/PHN2002383.
Camp RL, Charette LA, Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000, 80: 1943-1949.
Hoos A, Cordon-Cardo C: Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest. 2001, 81: 1331-1338.
Sundquist M, Thorstenson S, Brudin L, Nordenskjold B: Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group. Breast Cancer Res Treat. 1999, 53: 1-8. 10.1023/A:1006052115874.
Chang SC, Ziegler RG, Dunn B, Stolzenberg-Solomon R, Lacey JV, Huang WY, Schatzkin A, Reding D, Hoover RN, Hartge P, Leitzmann MF: Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2006, 15: 334-341. 10.1158/1055-9965.EPI-05-0479.
Malin A, Matthews CE, Shu XO, Cai H, Dai Q, Jin F, Gao YT, Zheng W: Energy balance and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1496-1501. 10.1158/1055-9965.EPI-04-0880.
Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene. 1997, 14: 295-304. 10.1038/sj.onc.1200833.
Thompson HJ, Zhu Z, Jiang W: Dietary energy restriction in breast cancer prevention. J Mammary Gland Biol Neoplasia. 2003, 8: 133-142. 10.1023/A:1025743607445.
Jain M, Miller AB: Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat. 1997, 42: 43-55. 10.1023/A:1005798124538.
Kushi LH, Potter JD, Bostick RM, Drinkard CR, Sellers TA, Gapstur SM, Cerhan JR, Folsom AR: Dietary fat and risk of breast cancer according to hormone receptor status. Cancer Epidemiol Biomarkers Prev. 1995, 4: 11-19.
Harlan LC, Coates RJ, Block G, Greenberg RS, Ershow A, Forman M, Austin DF, Chen V, Heymsfield SB: Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiology. 1993, 4: 25-31. 10.1097/00001648-199301000-00006.
Verreault R, Brisson J, Deschenes L, Naud F, Meyer F, Belanger L: Dietary fat in relation to prognostic indicators in breast cancer. J Natl Cancer Inst. 1988, 80: 819-825. 10.1093/jnci/80.11.819.
Jakovljevic J, Touillaud MS, Bondy ML, Singletary SE, Pillow PC, Chang S: Dietary intake of selected fatty acids, cholesterol and carotenoids and estrogen receptor status in premenopausal breast cancer patients. Breast Cancer Res Treat. 2002, 75: 5-14. 10.1023/A:1016588629495.
Hislop TG, Kan L, Coldman AJ, Band PR, Brauer G: Influence of estrogen receptor status on dietary risk factors for breast cancer. CMAJ. 1988, 138: 424-430.
Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L: Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev. 2000, 9: 681-687.
Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001, 92: 720-729. 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T.
Giles GG, Simpson JA, English DR, Hodge AM, Gertig DM, Macinnis RJ, Hopper JL: Dietary carbohydrate, fibre, glycaemic index, glycaemic load and the risk of postmenopausal breast cancer. Int J Cancer. 2006, 118: 1843-1847. 10.1002/ijc.21548.
Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G: Breast cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst. 1997, 89: 766-775. 10.1093/jnci/89.11.766.
Wolk A, Bergstrom R, Hunter D, Willett W, Ljung H, Holmberg L, Bergkvist L, Bruce A, Adami HO: A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med. 1998, 158: 41-45. 10.1001/archinte.158.1.41.
Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL: Body mass and stage of breast cancer at diagnosis. Int J Cancer. 2002, 98: 279-283. 10.1002/ijc.10209.
Kim YA, Lee CW: Effects of obesity on breast cancer stage at diagnosis in Korean women. Eur J Cancer Prev. 2004, 13: 13-17. 10.1097/00008469-200402000-00003.
Willett WC, Leibel RL: Dietary fat is not a major determinant of body fat. Am J Med. 2002, 113 Suppl 9B (): 47S-59S. 10.1016/S0002-9343(01)00992-5.
Willett WC: Nutritional Epidemiology. 1998, Oxford: Oxford University Press, 2
Mattisson I, Wirfalt E, Aronsson CA, Wallstrom P, Sonestedt E, Gullberg B, Berglund G: Misreporting of energy: prevalence, characteristics of misreporters and influences on observed risk estimates in the Malmö Diet and Cancer cohort. Br J Nutr. 2005, 94: 832-842. 10.1079/BJN20051573.
Wirfalt E, Mattisson I, Gullberg B, Berglund G: Food patterns defined by cluster analysis and their utility as dietary exposure variables: a report from the Malmo Diet and Cancer Study. Public Health Nutr. 2000, 3: 159-173.
Sonestedt E, Wirfalt E, Gullberg B, Berglund G: Past food habit change is related to obesity, lifestyle and socio-economic factors in the Malmo Diet and Cancer Cohort. Public Health Nutr. 2005, 8: 876-885. 10.1079/PHN2005736.